Skip to Navigation Skip to Search Skip to Content
Search All Centers

Is Refractory Myeloma a Life Sentence?

View next

Will refractory myeloma still respond to various drugs once they’ve been used earlier in treatment? Many patients worry once the cancer progresses, whether it’s possible to revisit some of the same drugs used in the initial treatment or will they be refractive to those agents forever. Dr. Robert Orlowski explains how some drugs can indeed show response if used in a different combinations rather than drugs used as a single agent.

Featuring

Partners

Multiple Myeloma Opportunities for Research and Education (MMORE) The University of Texas MD Anderson Cancer Center

Sponsors

The University of Texas MD Anderson Cancer Center
View next